Athanasios Samaras
Overview
Explore the profile of Athanasios Samaras including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
63
Citations
279
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Papadopoulos S, Peteinidou E, Theodoropoulos K, Didagelos M, Samaras A, Boulmpou A, et al.
Turk Kardiyol Dern Ars
. 2025 Mar;
53(2):143-147.
PMID: 40035248
Managing dual antiplatelet therapy (DAPT) perioperatively is challenging, especially in patients who have recently undergone percutaneous coronary intervention (PCI). Intravenous antiplatelet agents are recommended in these cases. This case series...
2.
Karakasis P, Pamporis K, Siontis K, Theofilis P, Samaras A, Patoulias D, et al.
Eur Heart J
. 2024 Oct;
PMID: 39428997
Background And Aims: Current guidelines suggest that asymptomatic atrial fibrillation (AF) is independently associated with increased risks of stroke and mortality compared with symptomatic AF. Considering that recent investigations have...
3.
Kofos C, Papazoglou A, Rousopoulou S, Douki P, Takas A, Samaras A, et al.
Hellenic J Cardiol
. 2024 Oct;
PMID: 39414026
No abstract available.
4.
Stachteas P, Nasoufidou A, Karagiannidis E, Patoulias D, Karakasis P, Alexiou S, et al.
J Clin Med
. 2024 Sep;
13(18).
PMID: 39336895
Atrial fibrillation (AF) is the most prevalent arrhythmia among adults worldwide, frequently co-occurring with comorbidities such as Heart Failure (HF) and Type 2 Diabetes Mellitus (T2DM). This association contributes to...
5.
6.
Kampaktsis P, Hennecken C, Shetty M, McLaughlin L, Rampidis G, Samaras A, et al.
Curr Cardiol Rep
. 2024 Jul;
26(10):1047-1062.
PMID: 39066990
Purpose Of Review: To summarize the current use of cardiac computed tomography (CT) technologies as well as their pertinent evidence in regards to prevention of coronary artery disease (CAD). Recent...
7.
Karakasis P, Patoulias D, Popovic D, Pamporis K, Theofilis P, Nasoufidou A, et al.
Curr Probl Cardiol
. 2024 Jul;
49(9):102742.
PMID: 39002620
Background Clinical and translational research suggests that mineralocorticoid receptor antagonists (MRAs) may prevent atrial fibrosis and electrical remodeling associated with atrial fibrillation (AF). This study aimed to consolidate existing evidence...
8.
Kassimis G, Samaras A, Nasoufidou A, Theodoropoulos K, Didagelos M, Rampidis G, et al.
Coron Artery Dis
. 2024 Jul;
35(8):705-706.
PMID: 38989960
No abstract available.
9.
Nteli M, Nteli D, Moysidis D, Foka A, Zymaris P, Grantza T, et al.
J Clin Med
. 2024 Jun;
13(11).
PMID: 38893005
: Contradictory results have been reported regarding the influence of obesity on the prognosis of atrial fibrillation (AF). The present study aimed to explore the potential association of body mass...
10.
Pamporis K, Karakasis P, Sagris M, Zarifis I, Bougioukas K, Pagkalidou E, et al.
Curr Probl Cardiol
. 2024 May;
49(7):102615.
PMID: 38692445
Introduction: Several randomized controlled trials (RCTs) have examined mineralocorticoid receptor antagonists (MRAs) in heart failure (HF) with reduced ejection fraction (HFrEF). This systematic review and network meta-analysis (NMA) evaluated the...